155 related articles for article (PubMed ID: 10364356)
1. Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice.
Jia Q; Ohka S; Iwasaki K; Tohyama K; Nomoto A
J Virol; 1999 Jul; 73(7):6041-7. PubMed ID: 10364356
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.
Jia Q; Hogle JM; Hashikawa T; Nomoto A
J Virol; 2001 Dec; 75(23):11766-72. PubMed ID: 11689657
[TBL] [Abstract][Full Text] [Related]
3. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
[TBL] [Abstract][Full Text] [Related]
5. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
La Monica N; Meriam C; Racaniello VR
J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
[TBL] [Abstract][Full Text] [Related]
6. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons.
Bledsoe AW; Gillespie GY; Morrow CD
J Neurovirol; 2000 Apr; 6(2):95-105. PubMed ID: 10822323
[TBL] [Abstract][Full Text] [Related]
7. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA.
Shiroki K; Ishii T; Aoki T; Ota Y; Yang WX; Komatsu T; Ami Y; Arita M; Abe S; Hashizume S; Nomoto A
J Virol; 1997 Jan; 71(1):1-8. PubMed ID: 8985316
[TBL] [Abstract][Full Text] [Related]
8. Sabin attenuated LSc/2ab strain of poliovirus spreads to the spinal cord from a peripheral nerve in bonnet monkeys (Macaca radiata).
Ponnuraj EM; John TJ; Levin MJ; Simoes EAF
J Gen Virol; 2001 Jun; 82(Pt 6):1329-1338. PubMed ID: 11369876
[TBL] [Abstract][Full Text] [Related]
9. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence.
De Jesus N; Franco D; Paul A; Wimmer E; Cello J
J Virol; 2005 Nov; 79(22):14235-43. PubMed ID: 16254358
[TBL] [Abstract][Full Text] [Related]
10. Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.
La Monica N; Kupsky WJ; Racaniello VR
Virology; 1987 Dec; 161(2):429-37. PubMed ID: 2825415
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
[TBL] [Abstract][Full Text] [Related]
12. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
13. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
14. A new internal ribosomal entry site 5' boundary is required for poliovirus translation initiation in a mouse system.
Ishii T; Shiroki K; Hong DH; Aoki T; Ohta Y; Abe S; Hashizume S; Nomoto A
J Virol; 1998 Mar; 72(3):2398-405. PubMed ID: 9499100
[TBL] [Abstract][Full Text] [Related]
15. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.
Crotty S; Hix L; Sigal LJ; Andino R
J Gen Virol; 2002 Jul; 83(Pt 7):1707-1720. PubMed ID: 12075090
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.
Arita M; Nagata N; Sata T; Miyamura T; Shimizu H
J Gen Virol; 2006 Nov; 87(Pt 11):3317-3327. PubMed ID: 17030866
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
[TBL] [Abstract][Full Text] [Related]
18. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Nagata N; Kew O; Miyamura T
Dev Biol (Basel); 2001; 105():93-8. PubMed ID: 11763343
[TBL] [Abstract][Full Text] [Related]
19. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
Bouchard MJ; Lam DH; Racaniello VR
J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
